Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives

Author(s):  Trimble John O, Light Bob

Issue:  Nov/Dec 2017 - Volume 21, Number 6
View All Articles in Issue

Page(s):  530-535

Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 1
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 2
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 3
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 4
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 5
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Page 6

Download in electronic PDF format for $75

Abstract:  Transdermal compositions for hormone replacement are comprised of exogenous hormones that are biochemically similar to those produced endogenously by the ovaries or elsewhere in the body. In this work, estradiol, estriol, and testosterone were loaded in transdermal vehicles, prepared using one of three selected penetration enhancer mixtures: Vehicle 1 (olive oil and oleic acid), Vehicle 2 (isopropyl palmitate and lecithin), and Vehicle 3 (isopropyl myristate and lecithin). The influence of penetration enhancers on transdermal delivery was evaluated using Franz-type diffusion cells and Normal Human 3D Model of Epidermal Tissue. Results showed that drug delivery is affected by the penetration enhancer used in the transdermal composition.

Related Keywords: hormone replacement therapy, HRT, adverse effects, estradiol, estiol, biest, testosterone, estrogens, transdermal delivery, percutaneous delivery, skin penetration enhancer, skin permeation, olive oil, oleic acid, isopropyl palmitate, lecithin, isopropyl myristate, Franz-type diffusion cell, Normal Human 3D Model of Epidermal Tissue, human dermal models, hydrophile-lipophile balance, HLB, drug solubilizing, drug solubility

Related Categories: EXCIPIENTS, HRT, PEER-REVIEWED

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives
Trimble John O
, Light Bob
Nov/Dec 2017
Pg. 530-535

Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives
Trimble John
, Light Bob
May/Jun 2016
Pg. 250-256

Using Serum Hormone Analysis to Develop Hormone Replacement Therapy Regimens - Part 2
Ford Gina
, Garcia Lea
Jan/Feb 2001
Pg. 52-54

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2
Deleruyelle Laura J
Nov/Dec 2016
Pg. 447-454

Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1
Deleruyelle Laura J
Sep/Oct 2016
Pg. 359-364

Transdermals: The Skin as Part of a Drug Delivery System
Allen Loyd V Jr
Jul/Aug 2011
Pg. 308-315

Featured Excipient: Flavor Enhancing Agents
Allen Loyd V Jr
Jan/Feb 2003
Pg. 48-50

Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 3
Deleruyelle Laura J
Jan/Feb 2017
Pg. 6-16

The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women
Stephenson Kenna
, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2013
Pg. 74-85

View Sample
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1
Gillson George R
, Zava David T
Jul/Aug 2003
Pg. 250-256

Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review
Beshay Sarah M
, Rivera Gerard, Balthasar Jan, Florea Naomi
Jan/Feb 2015
Pg. 6-12

Veterinary Transdermal Medications: A to Z
Davidson Gigi S
Mar/Apr 2003
Pg. 106-113

Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy
Griffee Chris
, Delano Amy
Mar/Apr 2012
Pg. 110-114

Saliva Tests, Part 2: Salivary Hormones, Hormone Replacement Pharmacokinetics, and the Importance of Timely Testing
Kells John
, Dollbaum Charles M
Sep/Oct 2009
Pg. 392-399

Bioidentical Hormone Replacement Therapy, Part 3, A Review of
Wepfer Scott T
Mar/Apr 2002
Pg. 142-146

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
May/Jun 2018
Pg. 190-195

Establishing a Rationale for Compounding Hormone Replacement Therapy
Biundo Bruce
Jan/Feb 2024
Pg. 22-27

Chemical Penetration Enhancers
Newton Stephen J
Sep/Oct 2013
Pg. 370-374

Transdermal Delivery of Nisoldipine: Refinement of Vehicles
El Maghraby Gamal M
, Ahmed Amal A, Osman Mohamed A
Mar/Apr 2015
Pg. 152-160

Bioidentical Hormone Replacement Therapy, Part 2, A Review of
Wepfer Scott T
Jan/Feb 2002
Pg. 50-54

Return to Top